Paweł Rubiś Selected Research

Galectin 3 (LGALS3)

1/2023	Link between fibrosis-specific biomarkers and interstitial fibrosis in hypertrophic cardiomyopathy.
3/2021	Relationships between circulating galectin-3, extracellular matrix fibrosis and outcomes in dilated cardiomyopathy.
1/2020	Kinetics of selected serum markers of fibrosis in patients with dilated cardiomyopathy and different grades of diastolic dysfunction of the left ventricle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paweł Rubiś Research Topics

Disease

15	Fibrosis (Cirrhosis) 01/2023 - 12/2016
14	Heart Failure 01/2024 - 01/2007
12	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022 - 12/2016
5	Endocarditis 01/2023 - 04/2003
3	COVID-19 09/2023 - 01/2021
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2023 - 01/2017
3	Neoplasms (Cancer) 06/2017 - 12/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 01/2020
1	Rare Diseases (Rare Disease) 01/2023
1	Amyloidosis 01/2023
1	Ventricular Tachycardia 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Transthyretin-Related Hereditary Amyloidosis 01/2022
1	Body Weight (Weight, Body) 12/2021
1	Mitral Valve Insufficiency (Mitral Regurgitation) 12/2021
1	Dyspnea (Shortness of Breath) 12/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Bundle-Branch Block (Fascicular Block) 10/2020
1	Diabetes Mellitus 10/2020
1	Stroke (Strokes) 10/2020
1	Infections 01/2020
1	Bicuspid Aortic Valve Disease 12/2019
1	Aortic Coarctation 12/2019
1	Myocarditis (Carditis) 01/2015
1	Cardiogenic Shock 01/2015
1	Subclavian Steal Syndrome (Subclavian Steal) 08/2009
1	Necrosis 08/2009
1	Pathologic Constriction (Stenosis) 08/2008
1	Aortic Valve Disease 01/2004
1	Myocardial Infarction 04/2003
1	Autoimmune Diseases (Autoimmune Disease) 04/2003

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2016
5	CollagenIBA 01/2022 - 12/2016
5	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2017
5	Connective Tissue Growth FactorIBA 01/2020 - 12/2016
5	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2020 - 12/2016
5	procollagen type I carboxy terminal peptide (PICP)IBA 01/2020 - 12/2016
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023 - 01/2017
4	Collagen Type I (Type I Collagen)IBA 01/2020 - 12/2016
4	Peptides (Polypeptides)IBA 03/2018 - 12/2016
3	Galectin 3 (LGALS3)IBA 01/2023 - 01/2020
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 10/2020
3	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 01/2021
3	OximesIBA 01/2023 - 01/2020
3	Matrix Metalloproteinases (MMPs)IBA 03/2018 - 12/2016
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2017 - 12/2016
2	Troponin T (Troponin T1)IBA 01/2023 - 01/2021
2	Trinitrotoluene (TNT)IBA 01/2023 - 01/2021
2	GadoliniumIBA 02/2022 - 01/2021
2	Neprilysin (Neutral Endopeptidase)IBA 11/2020 - 01/2017
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2020 - 01/2017
2	Procollagen Type IIBA 03/2018 - 12/2016
2	EnzymesIBA 12/2016 - 04/2003
2	CreatinineIBA 08/2009 - 08/2008
1	Natriuretic PeptidesIBA 01/2024
1	ProcollagenIBA 01/2023
1	DiureticsIBA 01/2023
1	tafamidisIBA 01/2023
1	LDL CholesterolIBA 01/2023
1	Therapeutic UsesIBA 12/2022
1	mouse MIRN29 microRNAIBA 01/2022
1	Prealbumin (Transthyretin)IBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	dapagliflozinIBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2020
1	candesartanIBA 10/2020
1	Eplerenone (Inspra)FDA LinkGeneric 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Thrombin FDA Link 01/2020
1	FibrinIBA 01/2020
1	SodiumIBA 01/2020
1	SymportersIBA 01/2020
1	CholesterolIBA 12/2019
1	Fibrinogen (Factor I)FDA Link 12/2019
1	Proteins (Proteins, Gene)FDA Link 03/2018
1	OsteopontinIBA 03/2018
1	Collagen Type III (Type III Collagen)IBA 12/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2015
1	HDL CholesterolIBA 08/2009
1	Creatine Kinase (Creatine Phosphokinase)IBA 08/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2004
1	Immunoglobulin G (IgG)IBA 04/2003
1	Antiphospholipid AntibodiesIBA 04/2003
1	Immunoglobulin M (IgM)IBA 04/2003
1	anti-dsDNA autoantibodyIBA 04/2003
1	AntibodiesIBA 04/2003
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2003
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2003

Therapy/Procedure

5	Therapeutics 01/2024 - 01/2007
3	Heart-Assist Devices 09/2023 - 01/2018
1	Injections 12/2022
1	Cell Transplantation 12/2022
1	Liver Transplantation 01/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020
1	Extracorporeal Membrane Oxygenation 01/2015
1	Aftercare (After-Treatment) 01/2015